TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non–Q-wave myocardial infarction: A double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods
- 1 June 1998
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 135 (6), S353-S360
- https://doi.org/10.1016/s0002-8703(98)70265-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- ENOXAPARIN FOR THROMBOEMBOLISM PROPHYLAXIS IN SPINAL INJURYAmerican Journal of Physical Medicine & Rehabilitation, 1996
- Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemiaJournal of the American College of Cardiology, 1995
- Activation of blood coagulation by plaque rupture: Mechanisms and preventionThe American Journal of Cardiology, 1995
- Thrombin hypothesis of thrombus generation and vascular lesion formationThe American Journal of Cardiology, 1995
- Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4)British Journal of Haematology, 1992
- EnoxaparinDrugs, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222)British Journal of Haematology, 1987